Screening and analysis of adsorbents for pemphigus autoantibodies

Therapeutic Apheresis and Dialysis

Volumn 14, Issue 3, 2010, Pages 292-297

  Yamada, Hiromichi ^a   Itoh, Akira ^b   Hatanaka, Yoshihiro ^b   Tsukiji, Misuzu ^b   Takamori, Kenji ^c  

^a International Goodwill Hospital   (Japan)

^b Asahi Kasei Medical Co   (Japan)

^c JUNTENDO UNIVERSITY URAYASU HOSPITAL   (Japan)

Author keywords

Autoantibody; Desmoglein; Immunoadsorption; Immunoglobulin G subclass; Pemphigus

Indexed keywords

4 GUANIDINOPHENYLALANINE; ADSORBENT; ALANINE; ASPARAGINE; ASPARTIC ACID; AUTOANTIBODY; CYSTEINE; DESMOGLEIN 1 ANTIBODY; DESMOGLEIN 3 ANTIBODY; GLUTAMIC ACID; GLUTAMINE; GLYCINE; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G4; ISOLEUCINE; LEUCINE; LYSINE; METHIONINE; PEMPHIGUS ANTIBODY; PHENYLALANINE; PHENYLALANINE DERIVATIVE; PROLINE; SERINE; THIENYLGLYCINE; THIOPHENE ETHYLAMINE; THREONINE; TRYPTOPHAN; TYROSINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALINE; DESMOGLEIN 1; DESMOGLEIN 3; IMMUNOGLOBULIN G; LIGAND; MOLECULAR LIBRARY; THIOPHENE DERIVATIVE;

ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; BINDING AFFINITY; BLISTER; CASE REPORT; DRUG SCREENING; DRUG STRUCTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMOFILTRATION; HUMAN; HUMAN TISSUE; IMMUNOADSORBENT; IMMUNOADSORPTION; IN VIVO STUDY; MEDICAL RESEARCH; PEMPHIGUS; PLASMAPHERESIS; PRIORITY JOURNAL; TREATMENT OUTCOME; CHEMISTRY; IMMUNOLOGY; MOLECULAR LIBRARY; PROCEDURES;

AUTOANTIBODIES; DESMOGLEIN 1; DESMOGLEIN 3; HUMANS; IMMUNOGLOBULIN G; IMMUNOSORBENT TECHNIQUES; LIGANDS; PEMPHIGUS; PLASMAPHERESIS; SMALL MOLECULE LIBRARIES; THIOPHENES;

EID: 77952934639     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2010.00827.x     Document Type: Article

References (25)

1. Stanley JR, Amagai M. Pemphigus, bullous impetigo, and the staphylococcal scalded-skin syndrome. N Engl J Med 2006 355 : 1800 1810.
2. Hertl M, Eming R, Veldman C. T cell control in autoimmune bullous skin disorders. J Clin Invest 2006 116 : 1159 1166.
3. Amagai M, Komai A, Hashimoto T et al. Usefulness of enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus. Br J Dermatol 1999 140 : 351 357.
4. Kricheli D, David M, Frusic-Zlotkin M et al. The distribution of pemphigus vulgaris-IgG subclasses and their reactivity with desmoglein 3 and 1 in pemphigus patients and their first-degree relatives. Br J Dermatol 2000 143 : 337 342.
5. Sitaru C, Mihai S, Zillikens D. The relevance of the IgG subclass of autoantibodies for blister induction in autoimmune bullous skin diseases. Arch Dermatol Res 2007 299 : 1 8.
6. Takamori K, Yamada H, Morioka S, Ogawa H. Long term remission successfully achieved in severe types of pemphigus vulgaris and bullous pemphigoid by the use of plasmapheresis. Eur J Dermatol 1993 3 : 433 437.
7. Yamada H, Yaguchi H, Takamori K, Ogawa H. Plasmapheresis for the treatment of pemphigus vulgaris and bullous pemphigoid. Ther Apher 1997 1 : 178 182.
8. Harman KE, Albert S, Black MM. Guidelines for the management of pemphigus vulgaris. Br J Dermatol 2003 149 : 926 937.
9. Schmidt E, Klinker E, Opitz A et al. Protein A immunoadsorption: a novel and effective adjuvant treatment of severe pemphigus. Br J Dermatol 2003 148 : 1222 1229.
10. Shimanovich I, Herzog S, Schmidt E et al. Improved protocol for treatment of pemphigus vulgaris with protein A immunoadsorption. Clin Exp Dermatol 2006 31 : 768 774.
11. Yaguchi H, Yamada H, Takamori K. Immunoadsorption with tryptophan and phenylalanine column as an effective treatment of pemphigus vulgaris. Jpn J Apheresis 1997 16 : 128 132.
12. Ogata K, Yasuda K, Matsushita M, Kodama H. Successful treatment of adolescent pemphigus vulgaris by immunoadsorption method. J Dermatol 1999 26 : 236 239.
13. Lüftl M, Stauber A, Mainka A, Klingel R, Schuler G, Hertl M. Successful removal of pathogenic autoantibodies in pemphigus by immunoadsorption with a tryptophan-linked polyvinyl alcohol adsorber. Br J Dermatol 2003 149 : 598 605.
14. Eming R, Rech J, Barth S et al. Prolonged clinical remission of patients with severe pemphigus upon rapid removal of desmoglein-reactive autoantibodies by immunoadsorption. Dermatology 2006 212 : 177 187.
15. Günther C, Laske J, Frind A, Julius U, Pfeiffer C. Successful therapy of pemphigus vulgaris with immunoadsorption using the TheraSorb adsorber. J Dtsch Dermatol Ges 2008 6 : 661 663.
16. Eming R, Hertl M. Immunoadsorption in pemphigus. Autoimmunity 2006 39 : 609 616.
17. Tsunematsu H, Makisumi S. Interactions of derivatives of guanidinophenylglycine and guanidinophenylalanine with trypsin and related enzymes. J Biochem 1980 88 : 1773 1783.
18. Ishii K, Amagai M, Hall RP et al. Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins. J Immunol 1997 159 : 2010 2017.
19. Hirata N, Kuriyama T, Yamawaki N. Immusorba TR and PH. Ther Apher Dial 2003 7 : 85 90.
20. Ren J, Jia L, Xu L, Lin X, Pi Z, Xie J. Removal of autoantibodies by 4-mercaptoethylpyridine-based adsorbent. J Chromatogr B Analyt Technol Biomed Life Sci 2009 877 : 1200 1204.
21. Laffitte E, Skaria M, Jaunin F et al. Autoantibodies to the extracellular and intracellular domain of bullous pemphigoid 180, the putative key autoantigen in bullous pemphigoid, belong predominantly to the IgG1 and IgG4 subclasses. Br J Dermatol 2001 144 : 760 768.
22. Hamano H, Kawa S, Horiuchi A et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001 344 : 732 738.
23. Liu LJ, Chen M, Yu F, Zhao MH, Wang HY. IgG subclass distribution, affinity of anti-myeloperoxidase antibodies in sera from patients with Wegener's granulomatosis and microscopic polyangiitis. Nephrology 2008 13 : 629 635.
24. Engelmann R, Brandt J, Eggert M et al. IgG1 and IgG4 are the predominant subclasses among auto-antibodies against two citrullinated antigens in RA. Rheumatology 2008 47 : 1489 1492.
25. McConville J, Farrugia ME, Beeson D et al. Detection and characterization of MuSK antibodies in seronegative myasthenia gravis. Ann Neurol 2004 55 : 580 584.